Acetylleucine
Names | |
---|---|
IUPAC name
2-Acetamido-4-methylpentanoic acid[1] | |
Identifiers | |
3D model (JSmol) |
|
3DMet | B00487 |
1724849 S | |
ChEBI | |
ChemSpider | |
ECHA InfoCard | 100.002.486 |
EC Number | 202-734-9 |
985259 S | |
KEGG | |
MeSH | acetylleucine |
PubChem CID |
|
UNII | |
| |
| |
Properties | |
C8H15NO3 | |
Molar mass | 173.21 g·mol−1 |
Appearance | White crystals |
Melting point | −115 to −113 °C; −175 to −172 °F; 158 to 160 K |
log P | −0.265 |
Acidity (pKa) | 3.666 |
Basicity (pKb) | 10.331 |
Pharmacology | |
N07CA04 (WHO) | |
Related compounds | |
Related compounds |
ENU |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Acetylleucine is a drug used in the treatment of vertigo.[2]
See also
References
- ↑ "N-Acetyl-DL-leucine". PubChem Open Chemistry Database. Retrieved 26 Mar 2017.
- ↑ "N07CA04 (acetylleucine)". WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health. 19 Dec 2016. Retrieved 26 Mar 2017.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.